Filing Details
- Accession Number:
- 0001209191-20-053071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-02 16:06:31
- Reporting Period:
- 2020-10-02
- Accepted Time:
- 2020-10-02 16:06:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780556 | David Jakeman | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-10-02 | 4,270 | $2.48 | 85,117 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit award granted on September 26, 2019.
- Includes 1,511 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on September 10, 2020.